Synthesis and biological evaluation of carbohydrate-mimetics as ligands for Siglecs

Mesch, Stefanie. Synthesis and biological evaluation of carbohydrate-mimetics as ligands for Siglecs. 2011, Doctoral Thesis, University of Basel, Faculty of Science.


Official URL: http://edoc.unibas.ch/diss/DissB_9731

Downloads: Statistics Overview


Sialic acid binding immunoglobulin-like lectins (Siglecs) play an important role in the mediation of cell-cell interactions as well as in the regulation of signaling pathways.
They are mainly expressed in the haematopoietic and immune system, with exception of Siglec-4, also called myelin-associated glycoprotein (MAG). It was identified as one of neurite outgrowth inhibitors, playing a crucial role in paraplegia, which is caused by injuries of the central nervous system (CNS) and especially young people suffer from these severe consequences as, for example, the loss of motor functions. The lack of repair of the injured nerve strands originates from the inhibitory environment for axon regeneration in the CNS. SpeciÞc inhibitory proteins, such as MAG block the regrowth of nerve roots. We identiÞed potent small molecule MAG antagonists modifies in the 2- and 5-position. Furthermore, we investigated new neuraminic acid derivatives modiÞed in the 4-position, and the inßuence of various structural modiÞcations on their kinetic and thermodynamic binding properties. In a next step we presented high affinity ligands, which were identified in second-site screenings and optimized them according to medicinal chemistry aspects. All ligands were elucidated with respect to their binding affinity as well as their kinetic and thermodynamic profile.
Siglec-2, also known as CD22, is involved in the regulation and survival of B-cells and has been successfully targeted in cell depletion therapies with antibody-based approaches. Sialic acid derivatives, already known to bind with high affinity to myelin-associated glycoprotein (MAG, Siglec-4), were screened for their binding affinity for CD22 by surface plasmon resonance. The best compound identified was further modified with various hydrophobic substituents at the 2-, 5-, and 9-positions of the sialic acid scaffold, leading to nanomolar derivatives. Furthermore, initial tests regarding drug-like properties of these antagonists demonstrate the required high plasma protein binding yet a lack of oral availability, although its distribution coefficient (log D) is in the required range.
Finally, we investigated a library of sialic acid mimetics with respect to binding towards another member of the Siglec family, namely Sialadhesin and discuss the influence of various structural moieties with regard to the arising selectivity towards these three proteins.
Advisors:Ernst, Beat
Committee Members:Giese, Bernd
Faculties and Departments:05 Faculty of Science > Departement Pharmazeutische Wissenschaften > Ehemalige Einheiten Pharmazie > Molekulare Pharmazie (Ernst)
UniBasel Contributors:Mesch, Stefanie and Ernst, Beat and Giese, Bernd
Item Type:Thesis
Thesis Subtype:Doctoral Thesis
Thesis no:9731
Thesis status:Complete
Number of Pages:167 S.
Identification Number:
edoc DOI:
Last Modified:22 Jan 2018 15:51
Deposited On:23 Jan 2012 14:57

Repository Staff Only: item control page